Healthcare & Life Sciences

Story

Click Therapeutics completes USD52m Series B Financing co-led by HIG BioHealth Partners and Accelmed Partners

Click Therapeutics completes USD52m Series B Financing co-led by HIG BioHealth Partners and Accelmed Partners

Click Therapeutics (Click), a specialist in Digital Therapeutics as prescription medical treatments, has closed a USD52 million upsized Series B financing. The financing round was co-led by new investors HIG BioHealth Partners (HIG BioHealth) and Accelmed Partners II (Accelmed).